Could a common diabetes drug help manage gestational diabetes?

NCT ID NCT05482789

First seen Jan 09, 2026 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This pilot study is testing how exenatide, an FDA-approved drug for type 2 diabetes, works in pregnant women with gestational diabetes. Researchers want to see how the body processes the drug and how well it controls blood sugar after a meal. Only 13 women will take part, and the goal is to see if exenatide could be a helpful addition to current treatments like insulin.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GESTATIONAL DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Magee Womens Hospital of UPMC

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Exenatide (a diabetes drug injected under the skin)

What this could lead to

If it works, this could point toward a new treatment option for gestational diabetes when standard therapies are not enough.

What could go wrong

This is a very small pilot study with only 13 participants, so results may not apply widely. Exenatide is not yet proven safe or effective in pregnancy, and side effects like nausea are possible.

Conditions

The condition(s) this trial relates to.

gestational diabetes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.